ETBI SEC Suspension "because of concerns about the adequacy and reliability of publicly available information concerning ETBI since at least January 30, 2020 about, among other things, the company’s purported international marketing rights to an approved coronavirus treatment to potentially combat the Wuhan Coronavirus and disclosures by the company in their September 30, 2019 Quarterly Report regarding their issued and outstanding shares."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.